PSCR (Proto Script Pharmaceutical) Net Margin %: -112.70% (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Net Margin %?

Proto Script Pharmaceutical PSCR Net Margin % is -112.70% as of Sep. 2017.

Net margin is calculated as Net Income divided by its Revenue. Proto Script Pharmaceutical's Net Income for the three months ended in Sep. 2017 was $-0.28 Mil. Proto Script Pharmaceutical's Revenue for the three months ended in Sep. 2017 was $0.25 Mil. Therefore, Proto Script Pharmaceutical's net margin for the quarter that ended in Sep. 2017 was -112.70%.

The historical rank and industry rank for Proto Script Pharmaceutical's Net Margin % or its related term are showing as below:


PSCR's Net Margin % is not ranked *
in the Business Services industry.
Industry Median: 3.85
* Ranked among companies with meaningful Net Margin % only.

Proto Script Pharmaceutical  (OTCPK:PSCR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Proto Script Pharmaceutical Net Margin % Related Terms

Proto Script Pharmaceutical Net Margin % Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Net Margin % Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Net Margin %
0.00 0.00 0.00 0.00 0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -7,264.00 -366.67 -292.11 -112.70

PSCR vs EXCC, NXES, PRZM: Net Margin % Comparison

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proto Script Pharmaceutical Net Margin % vs Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Net Margin % falls into.


Proto Script Pharmaceutical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Proto Script Pharmaceutical's Net Margin for the fiscal year that ended in May. 2016 is calculated as

Net Margin=Net Income (A: May. 2016 )/Revenue (A: May. 2016 )
=-0.033/0
= %

Proto Script Pharmaceutical's Net Margin for the quarter that ended in Sep. 2017 is calculated as

Net Margin=Net Income (Q: Sep. 2017 )/Revenue (Q: Sep. 2017 )
=-0.284/0.252
=-112.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -112.70% mean?
Proto Script Pharmaceutical (PSCR) has a Net Margin % of -112.70% as of Sep. 2017. Net margin is the ratio of total net income to net sales. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Net Margin % too high?
Proto Script Pharmaceutical's current Net Margin % is -112.70%.
How does Proto Script Pharmaceutical's Net Margin % compare to EXCC and NXES?
Proto Script Pharmaceutical's Net Margin % of -112.70% can be compared against companies in the Business Services industry. The industry median Net Margin % is 3.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Business Services company?
The median Net Margin % among Business Services companies is 3.85, based on 1,071 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Proto Script Pharmaceutical and its competitors. For the Business Services industry, the median Net Margin % is 3.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proto Script Pharmaceutical's current Net Margin % is -112.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Net Margin % of -112.70%. The current Net Margin % is -112.70%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Net Margin % is -112.70% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.